Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

NCT06872489 is registered in ClinicalTrials.gov with Second Life Therapeutics as lead sponsor.

NCT NCT06872489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06872489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors
Lead sponsor
Second Life Therapeutics
Phase
Expanded access
Overall status
Available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, advanced malignant neoplasm, gastrointestinal cancers, head and neck cancer, lung cancer - non small cell, lung cancer non-small cell cancer (nsclc), neuroblastoma in children, neuroblastoma, recurrent, refractory, pancreatic cancer, prostate cancer patients with bone metastasis